BBIC is a leading life-sciences incubator with deep expertise in biotechnology, pharmaceuticals, and medical innovation. It provides startups with access to advanced laboratory infrastructure, regulatory guidance, and a strong clinical–industry network. For CELLF Therapeutics, BBIC enables early-stage drug discovery, formulation development, and translational research within a robust, compliance-aware ecosystem.
NRDC is India’s premier technology commercialization and IP management organization, specializing in patenting, licensing, and market transfer of research-driven innovations. Its expertise lies in protecting scientific inventions and converting them into viable commercial assets. Through NRDC, CELLF receives structured support in IP strategy, patent filing, and technology monetization—critical for building a strong, defensible biopharma pipeline.